April 1, 2022 Mr. Todd Longsworth Novocure USA LLC Portsmouth, NH 03801Release Agreement • April 7th, 2022 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purpose of this letter (this “Agreement”) is to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability company (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date specified above (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of February 3, 2017 (the “Prior Agreement”) and you acknowledge and agree that your execution and delivery of this Agreement does not constitute a termination of employment for “Good Reason” as defined in the Prior Agreement.
